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Introduction
Inflammation and oxidative stress (OS) are common factors 
involved in the pathogenesis of several retinal diseases that eventually 
end in vision loss and blindness, such as age‐related macular 
degeneration (AMD), diabetic retinopathy (DR), retinitis pigmentosa 
and uveitis [1‐5]. Most of the studies on the above‐ mentioned 
diseases have been focused on the neural retina. However, in view 
of the importance of the retinal pigment epithelium (RPE) in the 
maintenance of photoreceptors´ (PR) viability and visual function, 
elucidating the effects of the inflammatory process in these cells could 
lead to the discovery of new therapeutic targets for the treatment of 
retinal degenerative diseases.
The RPE is located between the Burch´s membrane, which 
separates RPE cells from the choriocapillaris, and the light‐sensitive 
retina, with the apical membrane of RPE cells facing photoreceptor 
outer segments (POS) [6]. This monolayer of multifunctional 
pigmented cells is essential for the integrity and function of the retina 
[6,7]. Among its functions are light absorption and protection against 
photo‐oxidation, POS phagocytosis, nutrient and water transport, 
secretion of several growth factors and reisomerization of all‐trans‐
retinal [6]. The RPE also behaves as the outer blood‐retinal barrier 
(BRB) participating in the immune privilege of the retina. Tight 
junctions among neightbouring RPE cells are essential in the control 
of fluids, solutes as well as toxic molecules that cross the BRB [7].This 
epithelium is in the unique position to sense the circulating immune 
system status and has both macrophage and microglia‐like activities 
in the retina [8].
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cells. Moreover, PPARα agonists were observed to be able to reduce 
the LPS‐induced production of TNF‐α and ICAM‐1 in ARPE‐19 cells 
[20]. In contrast, under our experimental conditions, ARPE‐19 cells 
treated with different Pseudomona aeruginosa LPS concentrations 
showed no changes in the expression of TLR4 [18]. Differential 
responses in TLR4 expression and also in RPE cell viability could be 
due to the different LPS bacterial sources used, which have not been 
specified in most of the literature available.
Under pathological conditions in which BRB integrity is 
compromised, complement proteins may leak into the retinal 
tissue, resulting in local complement activation. However, it has 
been reported that murine and human RPE express the genes of key 
complement components of the classical and alternative pathways 
[22,23]. The expression of complement genes in RPE cells was 
observed to be up regulated by LPS, IL‐6 and, to a greater extent, 
by IFN‐γ and TNF‐α treatment [23]. Therefore, the production of 
inflammatory cytokines by RPE cells under pathological conditions 
could regulate their own complement genes expression.
We have recently reported that ARPE‐19 cells express the 
classical phospholipase D isoforms (PLD1 and PLD2) and that 
LPS increases PLD activity in this RPE cell line [18]. PLD catalyzes 
phosphatidylcholine (PC) hydrolysis to generate the lipid second 
messenger, phosphatidic acid (PA), and choline. PA generated by 
PLD can be further hydrolyzed by lipid phosphate phosphatases 
(LPPs) in order to generate diacylglycerol (DAG), another lipid 
second messenger [24]. Thus, through the generation of DAG the 
PLD/LPPs pathway can mediate several cell responses by modulating 
the activity of DAG‐responding proteins, such as classical and novel 
protein kinases C (PKCs), chimaerins, DAG kinases, protein kinases 
D, mammalian unc13 and Ras guanine‐releasing protein, all of which 
present at least one DAG‐binding C1 domain [25‐28]. Previous 
reports have shown that the PLD pathway plays important roles in 
macrophage functions, such as chemotaxis, phagocytosis, inducible 
nitric oxide synthase (iNOS) expression and NO production 
[29‐32]. However, findings from our laboratory demonstrated for 
the first time that PLD1 and PLD2 exert key functions during the 
inflammatory process in RPE cells [18]. After sustained stimulation 
of RPE cells with LPS, the subsequent activation of PLD2, ERK 
and the enhanced expression of cyclooxygenase 2 (COX‐2) and 
PGE2 production, mediate RPE cell damage, possibly through PGE2 
paracrine or autocrine effects. However, the role of PLD1 under 
inflammatory conditions in the RPE is not yet clear because although 
this isoform has the ability to promote cell damage through an ERK‐
independent COX‐2 induction it also seems to have the ability to 
modulate cellular protective mechanisms as well since its inhibition 
is not able to counteract LPS‐induced loss of cell viability [18]. Our 
results demonstrated that the PLD pathway is a novel player in the 
inflammatory response of the RPE. These findings, together with the 
development of new selective PLD isoform inhibitors [18,33‐36], lead 
us to consider that PLD2 and ERK could be potential therapeutic 
targets for the treatment of inflammatory ocular pathologies. Figure 1 
summarizes LPS‐induced responses in RPE cells.
RPE Responses to High Glucose (HG) Concentrations
Diabetes is now recognized as a global epidemic. This chronic 
disease causes progressive damage to many organs and tissues and 
DR is one of the most serious diabetic complications and one of the 
leading causes of visual dysfunction and blindness of the working‐
age adults worldwide [7,37‐39]. Retinal vasculature is particularly 
vulnerable to be damaged in patients with diabetes, this damage 
is characterized by microvascular lesions, impaired blood flow 
regulation, increased vasopermeability, microaneurysm formation, 
and eventually widespread non‐perfusion and ischemia [40,41]. 
Chronic hyperglycemia associated with OS, accelerated formation 
of advanced glycation endproducts (AGEs) and inflammation are 
key players in the pathogenesis of DR [7,39,42]. DR can be classified 
into non‐proliferative diabetic retinopathy (NPDR) and proliferative 
diabetic retinopathy (PDR). Neovascularization due to severe hypoxia 
is the hallmark of PDR whereas vascular leakage produced by BRB 
RPE cells can mediate the immune response in the eye because 
they i) express innate as well as adaptive immune receptors [9,10], ii) 
secrete immunomodulatory factors, such as interleukins (IL‐6, 8, 11), 
tissue‐ necrosis factor‐ (TNF‐β), interferon‐ (INF‐β) , complement 
factor H (CFH) and monocyte chemotactic protein‐1 (MCP1) and 
iii) inhibit T cells and macrophages through the modulation of IL‐2 
receptor and CD71 surface expression as well as IL‐10 and pigment 
epithelial‐derived factor (PEDF) secretion [11,12].
Although the intracellular mechanisms that mediate the RPE 
response to inflammatory and oxidative injury have not been fully 
elucidated to date, this review will summarize signaling events elicited 
in RPE cells under stress conditions and the participation of these 
signaling pathways in RPE viability and functions.
Lipopolysaccharide (LPS)‐ Elicited Signaling Pathways 
in the RPE
Although bacterial endophthalmitis (posterior segment eye 
infection) is an unusual pathology, it is a vital ocular emergency since 
it has poor prognosis and usually ends in vision loss [13,14]. This 
pathology can appear as a consequence of eye surgery, intravitreal 
injections, trauma or sepsis (endogenous endophthalmitis) [13‐16]. 
Endogenous endophthalmitis is mostly seen in immunocompromised 
patients [16].
Previous research has demonstrated that RPE cells isolated from 
human healthy donors and the human RPE cell line (ARPE‐19) can 
respond to the bacterial endotoxin since they express the primary 
LPS receptor, CD14, and its membrane‐linked co‐receptor, toll‐like 
receptor 4 (TLR4) [17,18]. LPS induces ARPE‐19 cells to secrete 
high levels of IL‐6, IL‐8, INF‐γ, MCP‐1 and intercellular adhesion 
molecule‐1 (ICAM‐1) and, to a lesser extent, IL‐4, IL‐5 and IL‐10 
[2,15,19]. Furthermore, Leung and collaborators demonstrated that 
ARPE‐19 cells express several cytokine receptors (IL‐R) for anti‐
and pro‐inflammatory cytokines. Cell death was also observed to 
be induced in ARPE‐19 cells by LPS, IL‐6 or IL‐8 treatment [2]. The 
deleterious effect of these pro‐inflammatory cytokines was abolished 
when IL‐6R and IL‐8R were simultaneously silenced, thus suggesting 
that IL‐6 and IL‐ 8 mediate LPS cytotoxicity via autocrine signaling 
[2]. However, the release of MCP‐1 and IL‐10 could have potential 
benefic effects, indicating that the RPE may contribute either to the 
progression or prevention of retinal degenerative diseases depending 
on the inflammatory stimulus, namely pro‐inflammatory cytokines 
and/or LPS [2].
It was also demonstrated that LPS induces the activation of 
mitogen‐activated protein kinases (MAPKs), such as p38, the 
extracellular signal‐regulated kinase (ERK) and Jun kinase (JNK) 
in ARPE‐19 cells [18,19]. Jung and collaborators demonstrated that 
ERK and the nuclear transcription factor‐κB (NF‐κB) activation 
are necessary to induce IL‐6, MCP‐1, and ICAM‐1 genes. They 
also demonstrated that 15‐deoxy‐δ12,14‐ prostaglandin J2 (15d‐
PGJ2) inhibits LPS‐induced activation of ERK and NF‐κB and 
production of IL‐6, MCP‐1, ICAM‐1 in ARPE‐19 cells. Although 
this prostaglandin can activate the peroxisome proliferator‐activated 
receptor γ (PPARγ) transcription factor, these effects of 15d‐PGJ2 
were PPARγ‐independent [19].Therefore, leukocyte migration and 
adhesion mediated by IL‐6‐, MCP‐1‐, and ICAM‐1 can be reduced 
by 15d‐PGJ2 and may lead to the suppression of ocular inflammation 
[19].
Peroxisome proliferator‐activated receptor α (PPARα) is another 
transcription factor that is highly expressed in RPE cells [20]. Recent 
studies have found that PPARα activation ameliorates inflammation 
by inhibiting NF‐κB activity and pro‐inflammatory cytokine 
production in a type I diabetes experimental model [21]. Shen and 
collaborators demonstrated that LPS exposure induces a twofold 
increase in TLR4 expression in ARPE‐19 cells. They showed that either 
down‐regulation or deletion of PPARα leads to increased TLR4 levels, 
activation of NF‐κB signaling and inflammatory cytokine production 
in RPE cells. Likewise, PPARα activation decreases TLR4 levels and 
also inhibits the NF‐κB signaling pathway induced by LPS in RPE 
• Page 3 of 7 •ISSN: 2378-346XMateos et al. Int J Ophthalmol Clin Res 2015, 2:3
breakdown is the main event involved in the pathogenesis of diabetic 
macular edema (DME) [7].
In mammals, retinal glucose utilization is higher than in any 
other body tissue and the anatomical position of the RPE is critical 
to glucose supply to retinal neurons [43]. To satisfy the retina’s 
large requirement of glucose RPE cells express high levels of glucose 
transporters (GLUT) 1 and 3, GLUT‐1 being responsible for the 
inducible glucose transport based on metabolic demands [43,44]. 
Moreover, it was reported that GLUT‐1 is expressed on both the 
apical and the basolateral surface of human RPE cells [43].
Several in vitro studies in which glucose concentrations ranging 
between 25 and 33mM were used to mimic hyperglycemia have been 
carried out in order to investigate the effect of HG on RPE cells. 
Some of these studies reported that HG reduces RPE cell viability and 
induces apoptosis [42,45]. Kim and collaborators showed that HG 
down regulates GLUT‐1 protein expression and activity via a PKC‐
OS‐Akt signaling pathway in ARPE‐19 cells [46]. In addition, because 
GLUT‐1 mRNA levels were not affected by HG, the decreased levels 
of this transporter could be due to an increased degradation rate of 
the protein under HG conditions [46].
In human RPE cell lines, such as ARPE‐19 and D407, HG was 
observed to induce iNOS expression, NO production and cell 
injury [45,47‐49]. HG causes activation of p38 MAPK and ERK in 
ARPE‐19 cells [42,45] and the expression of ERK was observed to 
be upregulated in the RPE from streptozotocine‐induced diabetic 
rats [50]. Furthermore, the inhibition of p38 and ERK was found to 
abrogate the HG‐induced increase in iNOS, cell injury and levels of 
NO and nitrotyrosine [45]. The HG‐induced overexpression of iNOS 
in RPE cells triggers endothelial cell apoptosis through the PKR‐like 
endoplasmic reticulum kinase (PERK) pathway and mediates the 
decreased expression and function of p‐glycoprotein (P‐gp) in RPE 
cells [48,49]. Thus, hyperglycemia effects on RPE cells can mediate 
vascular endothelium and neural retina injury on account of the fact 
that P‐gp function prevents the accumulation of toxic drugs and 
metabolites in the subretinal space.
It has also been reported that the loss of RPE cell viability induced 
by HG is accompanied by a decrease in superoxide dismutase 
(SOD) activity, the main enzyme for protection against oxidative 
stress in RPE cells [42]. In line with this, HG promotes vascular 
endothelial growth factor (VEGF) production in human RPE cells 
         
Figure 1: LPS-induced responses in RPE cells
Schematic view of the LPS-induced intracellular signaling events in RPE cells. Asterisks indicate potential therapeutic targets for the treatment of retinal 
inflammatory diseases.
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via intracellular reactive oxygen species (ROS) production and 
STAT3 (signal transducer and activator of transcription‐3) activation 
[51]. Because VEGF is the major angiogenic factor [6,51,52], the 
effect of hyperglycemia on RPE cells plays an important role in the 
exacerbation of choroidal neovascularization (CNV).
The VEGF family includes VEGF‐A,‐B,‐C and ‐D and the placental 
growth factor. VEGFs play essential roles in vascular development, 
angiogenesis and lymphangiogenesis in tissues and tumors [53]. It is 
well known that VEGF‐A plays a key role in DR by increasing retinal 
vascular permeability and inducing neovascularization. However, the 
inhibition of VEGF‐A only partially decreases neovascularization 
and vessel hyperpermeability, suggesting that other VEGF family 
members may also be involved in this process [54,55]. VEGF‐C 
and VEGF‐D have been focus of research regarding their roles 
as regulators of lymphangiogenesis but intraocular expression of 
VEGF‐C and VEGF‐D has been less studied [53,56]. It was reported 
that VEGF‐C can promote survival of retinal vascular endothelial cells 
and that this can be regulated by both TNF‐α and hyperglycemia [55]. 
The increased expression of VEGF‐C in the retinal vasculature DR 
patients further supports a role for VEGF‐C in DR [55]. In ARPE‐19 
cells VEGF‐A, VEGF‐C and VEGF‐D expression was regulated by 
hypoxia. Furthermore, RPE cells markedly expressed VEGF‐C and 
‐D, as well as VEGF‐Ain AMD [53].
As to RPE VEGF production under HG conditions, Puddu and 
collaborators demonstrated that AGEs significantly increase the 
expression of their specific receptor (RAGE) as well as VEGF‐A and 
VEGF‐C secretion in ARPE‐19 cells [52]. AGEs are a heterogeneous 
group of molecules that accumulate during aging and in a faster 
rate in diabetic patients and are also involved in AMD pathogenesis 
[52,57,58]. Furthermore, apart from inducing protein‐cross linking 
and OS, AGEs can induce the activation of genes involved in OS and 
inflammation through the interaction with RAGE [58]. While AGEs‐
induced VEGF‐A secretion by RPE cells is dependent on RAGE 
upregulation, AGEs‐induced VEGF‐C secretion is independent on 
this receptor and the blockage of VEGF‐A with bevacizumab (anti‐
VEGF monoclonal antibody) does not affect VEGF‐C production by 
RPE exposed to HG [52]. These authors postulate that RPE VEGF‐C 
production could be responsible for the clinical failure of treatments 
using monoclonal antibodies against VEGF in several patients and 
that the control of hyperglycemia could indeed be determinant and 
responsible for inter individual responses. Moreover, it has recently 
been reported that human RPE cells treated with AGE‐bovine serum 
albumin show a complex regulation of pro‐ and anti‐inflammatory 
cytokine secretion. In line with this, anti‐inflammatory cytokines 
(IL‐10, IL‐1ra and IL‐9) were found to be overexpressed and some 
pro‐inflammatory cytokines (IL‐4, IL‐15, INF‐γ) were overexpressed 
whereas others were underexpressed (IL‐8, MCP1), thus suggesting 
a para‐inflammatory state of the RPE under these conditions [57].
As stated above, BRB breakdown produced by the disruption 
of tight junctions is the main event in DME pathogenesis [59,60]. 
A differential expression of tight junctions proteins, such as zonula 
occludens‐1 (ZO‐1), claudins and occludin was shown in ARPE‐19 
cells exposed to HG conditions for 2‐3 weeks [60], occludin and 
ZO‐1 levels were similar to those observed under normo‐glucose 
concentrations although a clear upregulation of claudin‐1 was 
evidenced, accompanied with an aberrant distribution of these 
proteins [60,61]. In addition, HG and HG plus IL‐1β were found to 
increase fibronectin and collagen IV expression in RPE cells but only 
the combination of HG and IL‐1β, a condition that better mimics 
diabetic milieu, dramatically increased the barrier permeability [61]. 
Nevertheless, inconsistent results were obtained when transepithelial 
electrical resistance was measured in RPE cells exposed to HG [60,62]. 
These differences could be due to different RPE cell lines used and to 
the period of time during which these cells were kept in confluent 
cultures.
In view of the above, it becomes clear that hyperglycemia can 
affect RPE cell viability and BRB integrity. Furthermore, under 
HG conditions RPE secretes growth factors and enters in a para‐
inflammatory state, which could lead either to retinal damage or to 
survival depending on the inflammatory scenario and stress duration.
Role of OS in RPE Pathology
As stated above, RPE integrity is necessary for PR cell maintenance 
and PR renewal. RPE physiology has a central role in the vision 
process. Both PR and RPE are constantly exposed to light and are 
therefore continuously under OS. For this reason, many efforts are 
being currently made to understand how RPE deals with OS and to 
elucidate the molecular mechanisms that involve OS injury in retinal 
pathologies.
OS is a condition with increased ROS levels, which can damage 
membrane lipids, proteins and nucleic acids affecting cell function 
and, in many cases, when cell anti‐oxidants defenses are overpassed, 
OS provokes cell death. OS has been reported to be one of the leading 
causes of several neurodegenerative diseases in the elderly [63] and, 
as stated above, OS is closely related to DR pathogenesis and HG can 
induce ROS generation and reduced SOD activity [42,51].
4‐Hydroxy‐2‐nonenal (HNE), a highly reactive end product of 
lipid peroxidation, is a common marker in several human pathologies 
that occur during aging, such as Alzheimer’s disease, Parkinson’s 
disease and arthritis [64,65]. HNE levels in the RPE have been related 
with aging and the detrimental lipofuscin generation [66,67]. In line 
with this, HG was observed to increase lipid peroxides generation 
in ARPE‐19 cells [46]. It has also been demonstrated that the 
antioxidants catalase and metallothioneins are reduced in the RPE of 
human donor eyes with age and with signs of AMD [68,69].
Furthermore, ARPE‐19 cells exposed to the oxidant tert‐
butylhydroperoxide (t‐BHP) resulted in ROS generation, glutathione 
depletion and apoptosis [70]. The inhibition of the MEK/ERK 
pathway was found to completely block t‐BHP‐induced apoptosis. 
On the contrary, neither JNKs nor p38 inhibition were observed to 
be able to counteract the deleterious effect of this oxidant [70]. In 
agreement with this, ERK was postulated as a potential target for the 
treatment of AMD [71].
On the other hand, cumulative evidence demonstrates that during 
OS RPE can also trigger the activation of survival signaling pathways 
for self‐protection as well as for PR cell death prevention [72]. The 
synthesis of neuroprotective compounds from docosahexaenoic acid, 
such as neuprotectin D1 (NPD1), has been reported in RPE cells [73]. 
It has been shown that the addition of NPD1 protects human RPE 
cells in culture from OS injury and also upregulates the expression of 
anti‐apoptotic proteins, such as Bcl‐2 and Bcl‐xL, and downregulates 
levels of pro‐apoptotic markers, such as Bax and Bad [73]. The 
inhibition of caspase 3 and a diminished COX‐2 expression have 
also been shown to be triggered by NPD1 during OS events [73] and 
phosphatidylinositol 3‐kinase (PI3K)/Akt activation is involved in 
the survival induced by NPD1 in RPE cells [74]. NPD1 synthesis has 
also been related to PR shedding by RPE and this phagocytic process 
has been shown to induce refractoriness against OS [75].
Autophagy has been proposed as another RPE protective 
mechanism against OS. RPE autophagy activation and protection 
against OS has been shown to be regulated by the inhibition of the 
PI3K‐Akt‐mTOR pathway [76,77]. Autophagosome activity has, in 
fact, been observed to be age‐dependent in control human donor 
specimens and mice. In contrast, eyes from AMD patients were found 
to evidence reduced levels of autophagy proteins [76] and decreased 
autophagy has been related with lipofuscin accumulation under 
pathological conditions [78]. In addition, HG‐induced autophagy 
in RPE was shown to be regulated by ROS and endoplasmic 
reticulum stress signaling mediated by PERK activation [79]. Figure 2 
schematizes HG and OS‐elicited signaling events in RPE cells.
Findings reported in this review clearly show the central role of 
the crosstalk among OS defenses, RPE and PR survival. The light 
shed on the above‐mentioned neuroprotective mechanisms is mostly 
proposed as an important topic in the screening of new therapeutic 
strategies for retinal degeneration diseases.
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Concluding Remarks
RPE cells are extremely resistant cells that are faced with different 
threats, such as toxins, UV light and ROS. Nevertheless, taking into 
account the different and essential roles exerted by the RPE for 
proper retina function, minor changes in RPE viability could lead to 
an important PR damage and, in consequence, to vision loss in vivo. 
As discussed, RPE response to inflammatory situations can mediate 
either retinal damage or survival depending on the inflammatory 
context and stress duration. Even though the response towards the 
stress could vary between RPE cell lines and primary RPE cell cultures, 
ARPE‐19 cells are broadly used for the study of RPE pathologies. 
However, some intracellular events, such as ERK and NF‐κB 
activation, as well as iNOS and COX‐2 induction seem to mediate 
RPE cell damage, independently of the nature of the stress inductor. 
Then, these signaling pathways should be considered as potential 
therapeutic targets for ocular inflammatory diseases. In addition, the 
inhibition of the PLD2/LPPs pathway emerges as a novel therapeutic 
strategy. Still, further experiments are needed to fully elucidate the 
participation of this DAG generating pathway in retinal and RPE 
inflammatory conditions. Therefore, the design of selective inhibitors 
for the above‐mentioned pathways opens a promising field for the 
treatment of retinal diseases (Figures 1,2).
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